Abstract 589P
Background
Circulating tumor DNA (ctDNA) based molecular residual disease (MRD) detection has been shown to predict prognosis and guide individualized management of colorectal cancer (CRC). The landmark point is usually set at 4-12 weeks post resection in consideration of the disturbance to cell-free DNA (cfDNA) by surgery. This study aimed to evaluate the feasibility of moving the landmark point to 1-week post resection.
Methods
The study prospectively and consecutively enrolled stage I-IV CRC patients who received R0 resection. Blood samples at baseline, post-operative day (POD) 7, POD30 and subsequent every 3-6 months surveillance were collected. The MRD status of all the samples were evaluated by the Burning Rock Patient-specific pROgnostic and Potential tHErapeutic marker Tracking (brPROPHETTM) approach. The cfDNA level, mean tumor mutant (MTM), positive predictive value (PPV) and negative predictive value (NPV) were compared between POD7 and POD30.
Results
In total, 164 eligible patients were enrolled. The median follow-up duration was 311 days (95% CI, 296-351) up to date. The brPROPHET displayed a high sensitivity of 95.1% (155/163) for detecting ctDNA preoperatively, with 88.5%, 96.1%, 96.2%, 100% in stage I to IV, respectively. Post-resection ctDNA positive rates were decreased to 15.2% (25/164) at POD7 and 12.8% (21/164) at POD30. The cfDNA levels of POD7 were significantly higher than those of baseline and POD30 (P<0.001). However, the MTMs were similar between POD7 and POD30 (P = 0.55). The accordance between POD7 and POD30 was 91.5% (150/164). For 6-month recurrence, the PPV was 13.6% vs 15.8% for POD7 and POD30, respectively, with NPV of 100% vs 98.2%. Of the 25 ctDNA positive patients at POD7, 9 turned negative at POD30 and had significantly lower ctDNA levels at POD7 than those who didn’t (P<0.001). Patients with decreased ctDNA from POD7 to POD30 had a higher ctDNA clearance rate during surveillance than those without decreased ctDNA (100% vs 30%, P = 0.02).
Conclusions
The performance of ctDNA detection in POD7 and POD30 was similar. Shift of the landmark time to 1-week post resection may provide an easier way to evaluate MRD status for prognostic stratification.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
570P - Subclasses of microsatellite-instability colorectal cancer with unique molecular features and immune cell infiltration patterns
Presenter: Kui Wu
Session: Poster session 10
571P - Artificial intelligence-powered analysis of tumor lymphocytes infiltration: A translational analysis of AtezoTRIBE trial
Presenter: Martina Carullo
Session: Poster session 10
572P - Neoantigen heterogeneity among subtypes in colorectal cancer
Presenter: Fuqiang Li
Session: Poster session 10
574P - Comparative analysis of the tumor immune microenvironment (TIME) in primary and metastatic sites of microsatellite stable (MSS) and microsatellite instability-high (MSI) colorectal cancer
Presenter: Marwan Fakih
Session: Poster session 10
575P - Impact of immunological alterations and post-operative biomarkers on long-term outcomes in patients with locally advanced rectal cancer: Results from the STAR-01 study cohort
Presenter: Francesca Negri
Session: Poster session 10
576P - Prognostic values of a modified diagnostic biopsy-adapted immunoscore based on double immunohistochemical staining in patients with locally advanced rectal cancer
Presenter: Qiang Zeng
Session: Poster session 10
577P - Systematically assessing the intratissue microbiota in 937 patients with colorectal cancer
Presenter: Huanzi Zhong
Session: Poster session 10
578P - Tissue-resident microbiota characterization in colorectal cancer metastases
Presenter: Philippe Stevens
Session: Poster session 10
579P - A clinico-imaging predictive artificial intelligence model of relapse in colon cancer using baseline CT scans
Presenter: América Bueno Gómez
Session: Poster session 10